Cerebrospinal fluid level of proNGF as potential diagnostic biomarker in patients with frontotemporal dementia

Cerebrospinal fluid level of proNGF as potential diagnostic biomarker in patients with frontotemporal dementia

IntroductionFrontotemporal dementia (FTD) is an extremely heterogeneous and complex neurodegenerative disease, exhibiting different phenotypes, genetic backgrounds, and pathological states. Due to these characteristics, and to the fact that clinical symptoms overlap with those of other neurodegenera...

Full description

Bibliographic Details
Main Authors: Francesca Malerba, Rita Florio, Ivan Arisi, Chiara Zecca, Maria Teresa Dell’Abate, Giancarlo Logroscino, Antonino Cattaneo
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Aging Neuroscience
Subjects:
frontotemporal dementia
proNGF
immunoassay
biomarker
diagnosis
neurodegenerative disease
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2023.1298307/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2023.1298307/full

Similar Items